Global Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4313346
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly and Company
  • LEO Pharma A/S
  • Novartis AG
  • MORE
Psoriasis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Psoriasis Treatment market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.

Market Insights
Psoriasis is a chronic, inflammatory, painful skin disease for which there is no cure with great negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation and to stop the skin cells from growing quickly. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence in some countries, significant unmet needs, promising pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of study, global psoriasis treatment market is segmented on the basis of drug class such as TNF Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its long-term safety with lower risk of infection and malignancy. Psoriasis treatment market is categorized on the basis of route of administration such as topical, oral and parenteral therapeutic drugs. Currently, topical therapeutic drugs hold largest market share due to its safety, more effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would show significant growth during forecast period because newly approved biologics are generally preferred in moderate to severe psoriasis. Psoriasis treatment market is currently dominated by North America, factors such as higher cost of therapy, higher number of psoriasis patient, government reimbursement policies fueling the growth of psoriasis treatment market in North America.

Market Competition Assessment:
The psoriasis treatment market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as AbbVie Inc., Amgen Inc., AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Stiefel Laboratories Inc. (GlaxoSmithKline plc.), Sun Pharmaceutical Industries and other.

Key Market Movements:
  • Factors such as higher prevalence psoriasis disease, increasing treatment awareness, higher treatment compliance and favorable reimbursement policies in some countries are driving the market growth of psoriasis treatment worldwide.
  • Due to the high unmet needs, vendors in the market are focusing in development of ideal treatment, promising pipeline molecule, rising access for the treatment medication in some developing countries, increase in incidence of psoriasis and skin disorders would fuel the growth of psoriasis treatment market during forecast period.
  • However, patent expiry of blockbuster drugs leads to generic erosion and adverse effects associated with the use of medication which would negatively impact the growth of psoriasis treatment market.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly and Company
  • LEO Pharma A/S
  • Novartis AG
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Psoriasis Treatment Market Snapshot
2.2 Global Psoriasis Treatment Market, by Drug Class, 2016 (US$ Bn)
2.3 Global Psoriasis Treatment Market, by Route of Administration, 2016 (US$ Bn)
2.4 Global Psoriasis Treatment Market Share, by Geography, 2016 (Value %)

Chapter 3 Psoriasis Treatment Market Analysis
3.1 Global Psoriasis Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Higher Prevalence of Psoriasis
3.2.1.2 Promising Pipeline Molecules
3.2.2 Challenges
3.2.3 Opportunities
3.2.3.1 Higher Unmet Needs
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Psoriasis Treatment Market

Chapter 4 Global Psoriasis Treatment Market, by Drug Class
4.1 Overview
4.2 Tnf Inhibitors
4.3 Vitamin D Analogues
4.4 Interleukin Blockers
4.5 Topical Corticosteroids
4.6 Other

Chapter 5 Global Psoriasis Treatment Market, by Route of Administration
5.1 Overview
5.2 Topical Therapeutic Drugs
5.3 Oral Therapeutic Drugs
5.4 Parenteral Therapeutic Drugs

Chapter 6 Global Psoriasis Treatment Market, by Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan and Rest of Apac)
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Abbvie Inc
7.2 Amgen Inc
7.3 Astrazeneca
7.4 Biogen
7.5 Boehringer Ingelheim
7.6 Celgene
7.7 Eli Lilly and Company
7.8 Johnson & Johnson
7.9 Leo Pharma A/S
7.10 Merck & Co., Inc
7.11 Novartis Ag
7.12 Pfizer, Inc
7.13 Stiefel Laboratories Inc. (Glaxosmithkline Plc)
7.14 Sun Pharmaceutical Industries

List of Figures
Figure 1 Psoriasis Treatment Market: Research Methodology
Figure 2 Global Psoriasis Treatment Market, by Drug Class, 2016 (US$ Bn)
Figure 3 Global Psoriasis Treatment Market, by Application, 2016 (US$ Bn)
Figure 4 Global Psoriasis Treatment Market Share, by Geography, 2016 (Value %)
Figure 5 Attractive Investment Proposition: Global Psoriasis Treatment Market, by Geography, 2016
Figure 6 Global Tnf Inhibitors Market for Psoriasis Treatment, 2015 - 2025 (US$ Bn)
Figure 7 Global Vitamin D Analogues Market for Psoriasis Treatment, 2015 - 2025 (US$ Bn)
Figure 8 Global Interleukin Blockers Market for Psoriasis Treatment, 2015 - 2025 (US$ Bn)
Figure 9 Global Topical Corticosteroids Market for Psoriasis Treatment, 2015 - 2025 (US$ Bn)
Figure 10 Global Other Drug Market for Psoriasis Treatment, 2015 - 2025 (US$ Bn)
Figure 11 Global Topical Therapeutic Drugs for Psoriasis Treatment Market, 2015 - 2025 (US$ Bn)
Figure 12 Global Oral Therapeutic Drugs for Psoriasis Treatment Market, 2015 - 2025 (US$ Bn)
Figure 13 Global Parenteral Therapeutic Drugs for Psoriasis Treatment Market, 2015 - 2025 (US$ Bn)
Figure 14 Latin America Psoriasis Treatment Market, 2015 - 2025 (US$ Bn)
Figure 15 Middle East and Africa Psoriasis Treatment Market, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Psoriasis Treatment Market
Table 2 Global Psoriasis Treatment Market, by Drug Class, 2015 - 2025 (US$ Bn)
Table 3 Global Psoriasis Treatment Market, by Route of Administration, 2015 - 2025 (US$ Bn)
Table 4 Global Psoriasis Treatment Market, by Geography, 2015 - 2025 (US$ Bn)
Table 5 North America Psoriasis Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 6 Europe Psoriasis Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 7 Asia Pacific Psoriasis Treatment Market, by Country, 2015 - 2025 (US$ Bn)
Table 8 Abbvie Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 9 Amgen Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 10 Astrazeneca: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 Biogen: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 Boehringer Ingelheim: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 Celgene: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 Leo Pharma A/S: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 17 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 18 Novartis Ag: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 19 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 20 Stiefel Laboratories Inc. (Glaxosmithkline Plc): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 21 Sun Pharmaceutical Industries: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca
  • Biogen
  • Boehringer Ingelheim
  • Celgene
  • Eli Lilly and Company
  • Johnson & Johnson
  • LEO Pharma A/S
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Stiefel Laboratories Inc. (GlaxoSmithKline plc)
  • Sun Pharmaceutical Industries
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll